Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Improving Access to Overdose Treatment (Short Title: OD Treatment Access)
The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Prevention (CSAP), is accepting applications for fiscal year (FY) 2017 Improving Access to Overdose Treatment (Short Title:
OD Treatment Access).
SAMHSA will award OD Treatment Access funds to
a Federally Qualified Health Center (FQHC), Opioid Treatment Program, or practitioner who has a waiver to prescribe buprenorphine to expand access to Food and Drug Administration (FDA)-approved drugs or devices for emergency treatment of known or suspected opioid overdose.
The grantee will partner with other prescribers at the community level to develop best practices for prescribing and co-prescribing FDA-approved overdose reversal drugs.
After developing best practices, the grantee will train other prescribers in key community sectors as well as individuals who support persons at high risk for overdose.
In 2013, SAMHSA released the Opioid Overdose Prevention Toolkit to help reduce the number of opioid-related overdose deaths and adverse events.
The OD Treatment Access grant program will utilize this toolkit and other resources to help the grantee train and provide resources for health care providers and pharmacists on the prescribing of drugs or devices approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose The OD Treatment Access grant program will also ensure the grantees establishes protocols to connect patients who have experienced a drug overdose with appropriate treatment, including medication-assisted treatment and appropriate counseling and behavioral therapies.
OD Treatment Access).
SAMHSA will award OD Treatment Access funds to
a Federally Qualified Health Center (FQHC), Opioid Treatment Program, or practitioner who has a waiver to prescribe buprenorphine to expand access to Food and Drug Administration (FDA)-approved drugs or devices for emergency treatment of known or suspected opioid overdose.
The grantee will partner with other prescribers at the community level to develop best practices for prescribing and co-prescribing FDA-approved overdose reversal drugs.
After developing best practices, the grantee will train other prescribers in key community sectors as well as individuals who support persons at high risk for overdose.
In 2013, SAMHSA released the Opioid Overdose Prevention Toolkit to help reduce the number of opioid-related overdose deaths and adverse events.
The OD Treatment Access grant program will utilize this toolkit and other resources to help the grantee train and provide resources for health care providers and pharmacists on the prescribing of drugs or devices approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose The OD Treatment Access grant program will also ensure the grantees establishes protocols to connect patients who have experienced a drug overdose with appropriate treatment, including medication-assisted treatment and appropriate counseling and behavioral therapies.
Related Programs
Substance Abuse and Mental Health Services_Projects of Regional and National Significance
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Substance Abuse and Mental Health Services Admin
Estimated Funding: $1,000,000
Office: Substance Abuse and Mental Health Services Admin
Estimated Funding: $1,000,000
Who's Eligible
Obtain Full Opportunity Text:
Improving Access to Overdose Treatment (Short Title: OD Treatment Access)
Additional Information of Eligibility:
SAMHSA is limiting eligibility to FQHCs (as defined in section 1861(aa) of the Social Security Act), opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations, and practitioners dispensing narcotic drugs pursuant to section 303(g) of the Controlled Substances Act.
The eligibility for this grant program is statutorily defined in Section 544 of the Public Health Service Act.
Full Opportunity Web Address:
http://www.samhsa.gov/grants/grant-announcements/sp-17-006
Contact:
Eileen BermudezOffice of Financial Resources, Division of Grants ManagementSubstance Abuse and Mental Health Services Administration (240) 276-1412
Agency Email Description:
FOACSAP@samhsa.hhs.gov
Agency Email:
FOACSAP@samhsa.hhs.gov
Date Posted:
2017-05-31
Application Due Date:
2017-07-31
Archive Date:
2017-08-30
Social Entrepreneurship
Spotlight
Calgary Social Enterprise Offers High-Tech Services by People with Autism
Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.
Learn How to Identify and Avoid Grant Scams
